Answer
Medication management is an ongoing, shared process. Keep one accurate, up-to-date list of every prescription, over-the-counter (OTC), vitamin, and herbal product, including dose, timing, and purpose. Take medicines as directed on the label or as instructed by a doctor or pharmacist, and ask questions if you do not understand the instructions. Set timers or reminders, turn on a light when reading labels, and use the dosing device that comes with a liquid medicine rather than a household spoon. Check active ingredients so you do not take two products with the same ingredient, and keep all medicines locked up and out of reach of children. Review the entire regimen with a clinician or pharmacist at least annually and after any hospital admission, because a structured medication review can find medicines that are unnecessary, ineffective, or harmful. For adults aged 65 and older, ask whether any medicine is potentially inappropriate and whether deprescribing is appropriate. Dispose of unused or expired medicines through a take-back option when possible.
Current evidence
Unsafe medication practices are common and preventable. WHO's technical report on polypharmacy notes that as populations age, more people live with multiple long-term illnesses and take multiple medicines, so a person-centred approach is needed to gain benefit without harm. In older adults, the number of prescribed drugs is the single most important predictor of inappropriate prescribing and of adverse drug event risk. Deprescribing is therefore a core part of good prescribing: it is the process of tapering or stopping drugs to minimise polypharmacy and improve outcomes, and it should start with ascertaining every drug and the reason for it, then judging benefit against harm and burden before prioritising and monitoring a discontinuation plan. The AGS Beers Criteria provide an explicit list of potentially inappropriate medications that are typically best avoided by older adults in most circumstances or under specific situations. NICE defines a structured medication review as a critical examination of a person's medicines aimed at agreeing treatment, optimising impact, minimising medication-related problems and reducing waste, and it recommends such reviews for people taking multiple medicines, people with long-term conditions, and older people. NICE also recommends medicines reconciliation, the process of identifying an accurate current list and comparing it with the list in use, when people move between care settings. For self-management, NICE recommends individualised, documented self-management plans that record the medicines, doses, monitoring, and when to seek advice. CDC's practical advice is consistent: keep a list, follow directions, take medicines on time, ask questions, keep monitoring tests, and use the correct dosing device for children. However, a Cochrane review of 182 randomised trials found that people prescribed self-administered medicines typically take only about half their prescribed doses, and that even the most effective adherence interventions did not produce large improvements in adherence or clinical outcomes. Safe disposal matters too: FDA advises using a drug take-back location or mail-back envelope first, flushing only medicines on its flush list, and otherwise mixing non-flush-list medicines with an unappealing substance in a sealed bag before trash disposal.
Limitations
Several limits qualify this guidance. The Cochrane review found marked heterogeneity in patients, conditions, regimens, adherence interventions, and outcome measures, and most included trials had a high risk of bias, so no single adherence strategy can be recommended as uniformly effective. The AGS Beers Criteria are designed for adults aged 65 and older in the United States and are explicitly intended to support, not replace, shared clinical decision-making; they are not a substitute for individual assessment of kidney and liver function, allergies, pregnancy, and drug interactions. NICE NG5 was published in 2015 and its 2019 surveillance found no new evidence affecting the recommendations, but it is written for the English health and social care system, and local formularies, availability, and monitoring requirements vary. WHO's polypharmacy report is a technical and policy document rather than a patient-level trial, and it does not specify one universal medication schedule. This answer is general: it cannot determine whether a particular medicine is appropriate for a particular person, and it does not cover every high-risk drug class or every interaction; individuals should confirm any change with their own prescriber or pharmacist.
What this means
What this means in practice is that medication management should be proactive and repeated, not a one-off prescription. Bring a complete list, or the actual bottles, to every appointment, and ask what each medicine is for, how long to take it, what side effects to watch for, and what to do about a missed dose. Use one pharmacy where possible so that a pharmacist can screen for interactions and duplicate therapy, and include OTC products, vitamins, and supplements in that conversation. At care transitions, ask for a written, reconciled list and compare it with what you were taking before; NICE recommends sharing complete and accurate information about medicines when a person moves from one care setting to another. Do not stop a medicine abruptly on your own; deprescribing should prioritise drugs with the lowest benefit-harm ratio and lowest likelihood of withdrawal reactions or disease rebound, then monitor closely. For older adults, a periodic review can reduce inappropriate polypharmacy, but the goal is optimised therapy, not simply fewer drugs. Finally, report suspected adverse reactions to your clinician or pharmacist, and use take-back disposal to reduce diversion and accidental poisoning.
EvidenceSources (7)
Last checked 2026-10-25Source details
Sources (7)
Confidence is an AI estimate, not an independent assessment of source quality.
- Medication Safety and Your Health
Centers for Disease Control and Prevention (CDC) · 2024-11-18
Reputable websiteAI confidence: 95% - Medication safety in polypharmacy: technical report
World Health Organization · 2019-06-20
GuidelineAI confidence: 93% - Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes (NICE guideline NG5)
National Institute for Health and Care Excellence (NICE) · 2015-03-04
GuidelineAI confidence: 96% - Reducing inappropriate polypharmacy: the process of deprescribing
Scott IA, Hilmer SN, Reeve E, et al. · 2015-05-01
Peer reviewedAI confidence: 95% - American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults
2023 American Geriatrics Society Beers Criteria Update Expert Panel · 2023-05-04
GuidelineAI confidence: 96% - Interventions for enhancing medication adherence
Nieuwlaat R, Wilczynski N, Navarro T, et al. · 2014-11-20
Peer reviewedAI confidence: 95% - Disposal of Unused Medicines: What You Should Know
U.S. Food and Drug Administration (FDA) · 2024-10-31
Reputable websiteAI confidence: 95%
Update history
- Initial answerVersion 1Initial answer generated from current guideline, review, and authoritative consumer safety sources; no prior draft was provided.7 sources · AI-generated